S L Gibson

Plain English
This study focused on improving end-of-life care planning for people with intellectual disabilities by creating a toolkit and engaging with various stakeholders throughout the project. Researchers found that effective public engagement, which included hosting webinars, sending newsletters, and using social media, helped raise awareness about the toolkit and led to positive outcomes, such as inclusion in national guidelines. These findings highlight the importance of involving people with intellectual disabilities in research to ensure that the developed resources meet their needs. Who this helps: This benefits patients with intellectual disabilities and their families.

Plain English
This study looked at how mental health issues like depression and anxiety affect the ability of people with cystic fibrosis (CF) to stick to their medical treatments. Researchers found that when these individuals experienced mental health symptoms, they reported more obstacles to managing their condition and felt less confident about taking their medications. Specifically, they discovered that experiencing these symptoms decreased medication adherence, with significant effects measured in both barriers and self-efficacy. Who this helps: This benefits patients with cystic fibrosis by improving their adherence to treatment plans through better mental health support.

Plain English
This study looked at how patients and their caregivers felt about using telehealth for pediatric lung care after the COVID-19 pandemic. Out of nearly 1,000 people surveyed, 71% found telehealth visits more convenient, and 95% thought it was an acceptable alternative to in-person appointments. While some patients had concerns about not being able to do in-person checks, 75% were not worried, and most (94%) would choose telehealth again in the future. Who this helps: This benefits children with lung issues and their families by providing convenient access to medical care.

Plain English
This study looked at a toolkit designed to help plan end-of-life care for people with intellectual disabilities, assessing whether it works well in social care settings. Out of 34 staff members who provided feedback, many found the toolkit helpful and appreciated the discussions it sparked, but they also faced challenges like printing materials and finding time to talk about sensitive issues. Addressing these challenges is crucial to effectively use this toolkit in caring for individuals at the end of their lives. Who this helps: This research benefits social care staff and the families of individuals with intellectual disabilities.

Plain English
This study looked at how people with intellectual disabilities, their families, and professionals view end-of-life care planning. Out of 60 participants, including individuals with intellectual disabilities and health professionals, it was found that there are different perspectives on topics like funeral and illness planning. While most agreed that planning is crucial and wanted to be part of the process, discussions often didn’t happen because of barriers like discomfort talking about death and confusion over how to start such conversations. Who this helps: This research benefits people with intellectual disabilities and their families by improving conversations about end-of-life care.

Plain English
This study focused on creating a toolkit to help support staff plan end-of-life care for people with intellectual disabilities. The research group, called the "All Together Group," met six times and included people with intellectual disabilities, their families, and care professionals. They developed three new visual resources to make planning easier, addressing feedback that existing materials were often too complicated. The final toolkit is available for free online, providing practical support for staff in these sensitive discussions. Who this helps: This toolkit benefits support staff and families of people with intellectual disabilities.

Plain English
This study looked at how well peer support workers—people with personal experiences of mental health challenges—are integrated into mental health services and how that affects their effectiveness. It found that when peer workers had more support and better relationships with clinical teams, patients were more engaged with the services, leading to fewer hospital readmissions. In the best-performing sites, engagement levels were high and aligned with peer support principles, while sites with less engagement faced challenges due to limited resources and poor relationships with staff. Who this helps: This benefits patients receiving mental health care and the peer workers supporting them.

Plain English
This study looks at a rare case of a young miniature donkey that developed paralysis of both sides of its diaphragm, which affected its breathing. The donkey had symptoms like fever and coughing, and tests showed it had a respiratory infection along with the paralysis. After treatment, the donkey recovered, highlighting that this condition should be considered when diagnosing breathing problems in donkeys that don't respond to typical treatments. Who this helps: This helps veterinarians who treat respiratory issues in donkeys.

Plain English
This study focused on a 65-year-old man with a serious heart condition called acute type I aortic dissection, where the inner layer of the aorta tears, causing dangerous complications. During surgery, a special ultrasound technique called transesophageal echocardiography helped doctors quickly see that blood was not flowing properly, which led to immediate intervention that saved his life. This is important because it shows how using this imaging method during surgery can lead to faster and more effective treatments for patients in critical situations. Who this helps: This benefits patients experiencing aortic dissection and their surgeons.

Plain English
This study looked at whether adding peer support to the usual care after discharge from psychiatric hospitals helps prevent patients from being readmitted within a year. Researchers found that 47% of patients receiving peer support were readmitted, compared to 50% in the usual care group, which means the peer support did not significantly lower readmission rates. This matters because if peer support is not effective at reducing readmissions, resources may be better spent on other strategies. Who this helps: This helps mental health professionals and healthcare planners figure out the best ways to support patients after discharge.

Plain English
This research focused on creating a peer support program to help people transition from hospital mental health care back to community services. The team, including individuals with personal experience in mental health care, identified 66 important elements for the program and refined these into a final version that includes training and guidelines for peer workers. The goal is to improve patient experiences and outcomes during this vulnerable time of discharge. Who this helps: This benefits patients leaving inpatient mental health care and the peer workers supporting them.

Plain English
This study looked at the impact of using peer support to help people transition from hospital to community mental health care. Researchers recruited 590 people and found that those who received peer support along with regular care were less likely to be readmitted to the hospital 12 months after discharge compared to those who only received standard care. This matters because it shows that having peer support during this critical transition can significantly reduce hospital readmissions, helping individuals maintain their mental health after leaving inpatient care. Who this helps: This helps patients recovering from mental health issues.

Plain English
This study looked at how drain care is managed in community settings, finding that many patients receive poor care because nurses don't consistently monitor these drains. It showed that inadequate handling can lead to complications for patients, emphasizing the need for better training and documentation. Improving how nurses manage and document drain care is crucial for ensuring patient safety and quality of care. Who this helps: Patients receiving treatment at home or in community healthcare settings.

Plain English
This research paper focuses on the importance of properly caring for medical drains used in patients, especially in community healthcare settings where such care is often overlooked. The study found that inadequate monitoring and documentation of drain care can lead to serious complications for patients, underscoring the need for nurses to be well-trained in managing these drains effectively. Improving drain care is crucial because it can directly impact patient safety and health outcomes. Who this helps: This benefits patients and nurses involved in community healthcare.

Plain English
The research looked at how peer workers—people with lived experience of mental health issues—help others in mental health services. By interviewing 71 individuals involved in ten different peer worker programs in England, the study found that successful peer support leads to positive changes by building trust, demonstrating recovery, and connecting users with needed services. This is important because it helps clarify how peer workers can effectively support mental health recovery, making future programs more successful. Who this helps: This benefits patients seeking mental health support.

Plain English
This study explored the inclusion of Peer Workers—people with personal experiences of mental health issues who support others—into mental health teams in the UK. Researchers spoke with 41 participants, including Peer Workers and mental health staff, and found that while Peer Workers were well-liked and beneficial, challenges arose due to unclear role expectations and lack of support, which could lead to feelings of inequality among Peer Workers. The findings highlight that for Peer Workers to be effective, their roles and practices must be clearly established and supported within the mental health teams. Who this helps: This benefits patients and mental health professionals by improving support systems in care settings.

Plain English
This study examined the relationship between ultrasound measurements and bone structure in samples from the heel bone (calcaneus) of humans. It found that ultrasound readings (like how the sound waves bounce back) are closely linked to bone density and specific structural features, with correlation scores ranging from 0.69 to 0.83. This matters because it helps understand how ultrasound can be used to assess bone health, which could lead to better screenings for conditions like osteoporosis. Who this helps: Patients at risk of bone diseases.

Plain English
This study focused on creating a tool to accurately measure polymerization stress (PS) in dental materials, which occurs when these materials shrink during hardening. Researchers developed a new device called a tensometer and found that its readings matched expected results, confirming the accuracy of their measurements. Understanding and measuring PS is important because it can affect the durability and performance of dental restorations, helping to improve patient outcomes. Who this helps: This helps dentists and dental patients who rely on high-quality restorative materials.

Plain English
This study looked at two proteins, IRS-1 and IRS-2, which play different roles in breast cancer spread. Researchers found that IRS-2 promotes the spread of cancer, while IRS-1 may help prevent it; specifically, they noted that IRS-1 is often inactive in cancers that have spread. This discovery is important because it suggests that measuring IRS activity, instead of just their levels, could help predict whether breast cancer will spread. Who this helps: This information benefits breast cancer patients and their doctors by offering new insights into diagnosis and treatment strategies.

Plain English
This study examined how overexpressing a gene called PMS2 affects DNA repair in cells. The researchers found that cells with high levels of PMS2 had many more mutations—around 60% higher when exposed to a damaging substance—and were more resistant to DNA damage compared to normal cells. This is important because it shows a new way that some cancer cells can become unstable and survive treatments that are meant to kill them. Who this helps: This helps cancer patients and doctors by highlighting potential new targets for therapy.

Plain English
This study looked at a protein called p16(INK4a) in patients with ulcerative colitis, a type of inflammatory bowel disease. Researchers found that in the intestinal tissues of these patients, p16 was present in 33% of cell clusters compared to less than 1% in healthy individuals, suggesting that p16 helps regulate cell growth under stress. This matters because understanding how p16 works in this disease could lead to better treatments and prevention strategies for patients with ulcerative colitis. Who this helps: Patients with ulcerative colitis and their doctors.

Plain English
Researchers studied a substance called IY69 to see how it kills cancer cells using light. They found that the longer the cancer cells were exposed to IY69, the more effective it was at triggering cell death, and they could observe specific types of cell death called apoptosis and necrosis. This matters because understanding how to use light and IY69 together might improve treatment options for breast cancer. Who this helps: This helps patients with breast cancer.

Plain English
This study looked at how low oxygen levels (hypoxia) affect a key protein involved in DNA repair called BRCA1. Researchers found that hypoxia triggers a specific change (phosphorylation) in BRCA1, which is regulated by another protein called CHK2. This discovery helps explain how cells respond to low oxygen and underscores the importance of BRCA1 in dealing with stressful conditions that can occur in tumors. Who this helps: This research benefits cancer patients and their doctors by improving understanding of how tumors respond to hypoxic conditions.

Plain English
This study looked at a protein called IRS-1 and its role in breast cancer spread. Researchers found that when IRS-1 was missing, breast cancer cells were able to spread significantly more, with a notable increase in their ability to invade other tissues, but the size of the original tumors didn't change much. Specifically, tumors without IRS-1 showed increased levels of another protein (IRS-2) and other biological activities that help promote cancer spread. Who this helps: This research benefits breast cancer patients by providing insight into potential targets for new treatments that could limit cancer spread.

Plain English
This study looked at different versions of a chemical compound called dithiaporphyrins to see how changes in their structure affected their ability to destroy cancer cells when exposed to light. They found that one specific compound, called 5-phenyl-20-(2-thienyl)-10,15-bis-(4-carboxylatomethoxy-phenyl)-21,23-dithiaporphyrin, was the most effective, killing 68% of targeted cancer cells at a very low concentration when exposed to light. These findings are important because they could lead to better treatments for cancer that use light to activate these compounds. Who this helps: This helps cancer patients by potentially improving photodynamic therapy treatments.

Plain English
This study explored different versions of a chemical compound called tetramethylrosamine (TMR) to see how they can be used in treating cancer cells that resist treatment. Researchers found that these new compounds, both thio and seleno versions of TMR, effectively killed regular cancer cells and even some resistant ones when used in combination with a drug called verapamil. Specifically, after using verapamil, the resistant cells took in similar amounts of these compounds as the sensitive cells, showing potential for overcoming treatment resistance. Who this helps: This research benefits cancer patients, particularly those with multidrug-resistant tumors.

Plain English
This study looked at new chemical compounds called dithiaporphyrins to see how their structures affect their ability to produce light and kill cancer cells in the lab. Although the changes in their structure didn't significantly affect their ability to absorb light or generate a toxic form of oxygen, certain compounds were effective at killing cancer cells. Specifically, one compound (compound 3) was found to kill 67% of cancer cells at a low concentration of 1 x 10(-7) M, showing promise for potential use in cancer treatments. Who this helps: This helps patients with cancer by informing the development of new therapies.

Plain English
This study looked at how low oxygen levels (hypoxia) affect a protein called Chk2, which plays a key role in helping cells respond to DNA damage. Researchers found that hypoxia activates Chk2 through a specific process involving another protein called ATM, and this activation is weakened in cells lacking certain DNA repair factors. The findings are important because they reveal a new way that hypoxia in tumors could help cancer cells survive and heal their DNA, making treatment challenges more complex. Who this helps: This helps doctors and researchers understand cancer cell behavior, which can improve treatments for patients with solid tumors.

Plain English
This study examined the role of a protein called p16 in the growth of colon tumors in mice. Researchers found that mice without p16 had tumors that were larger, had more dead tissue, and higher blood vessel density compared to those with p16. Specifically, tumors from p16-deficient mice showed 20% more necrosis and increased levels of a protein that promotes blood vessel growth, implying that p16 helps slow down tumor development by reducing blood supply to the tumors. Who this helps: This research benefits patients with colon cancer by providing insights into tumor growth mechanisms.

Plain English
This study looked at how low oxygen levels (hypoxia) affect the BRCA1 gene, which is important for repairing DNA in cells. Researchers found that in low oxygen conditions, the BRCA1 gene is less active, leading to problems with a specific DNA repair process called homologous recombination—this makes cells more prone to genetic errors. Specifically, they observed that hypoxia resulted in a 50% decrease in BRCA1 expression, thereby increasing reliance on a less reliable DNA repair method. Who this helps: This research helps cancer patients and their doctors by providing new insights into how the tumor environment can affect cancer development.

Plain English
This study looked at new versions of a compound called tetramethylrosamine, focusing on two variations that include sulfur (thio) and selenium (seleno). Researchers found that these new compounds absorbed light better and produced more singlet oxygen, which can help kill cancer cells, than the original compound. Specifically, they were effective at attacking rat breast cancer cells in laboratory tests, showing promise for future cancer treatments. Who this helps: This benefits cancer patients by potentially leading to more effective treatments.

Plain English
This study looked at how different dyes (specifically, thiopyrylium and selenopyrylium variants) affect cells when exposed to light and dark conditions. The researchers found that while the selenopyrylium dye AA1-Se significantly reduced cell survival from 81% to 46% when exposed to light, the thiopyrylium dyes were more harmful in the dark. Notably, the dye AA1 was the only one impacting a key mitochondrial function, indicating serious effects on cell health. Who this helps: This research benefits scientists and medical professionals exploring new treatments that target cell mitochondria, particularly in cancer therapy.

Plain English
This study looked at how certain chemical compounds, called tetramethylrosamine analogues (TMRs), can be used to help deliver medicine into cancer cells that resist treatment. Researchers found that when they used a drug called verapamil, it increased the amount of TMR compounds taken up by resistant cancer cells by the same amount seen in sensitive cells. The study also found that two of these compounds, when paired with light exposure after treatment with verapamil, caused notable damage to the resistant cancer cells, showing potential for better cancer treatment strategies. Who this helps: This helps cancer patients who deal with resistant tumors.

Plain English
This study looked at a specific genetic region, called the Ink4a/Arf locus, to see how it affects colon cancer progression in mice. Researchers found that mice missing this genetic area had larger and red tumors compared to those with the area intact—specifically, the tumors from the missing locus were about twice as vascular (more blood vessels) and had higher levels of important growth factors. These results matter because they show how this genetic region helps control colon cancer development, which is crucial for improving diagnosis and treatment options. Who this helps: This helps patients with colon cancer and doctors treating them.

Plain English
This study looked at modified porphyrin compounds, which are used in a type of cancer treatment called photodynamic therapy. The researchers created different versions of these compounds and tested how well they can generate reactive oxygen to kill cancer cells. They found that one particular compound (compound 2) was much more effective at killing cancer cells compared to other tested compounds, and it worked by targeting the mitochondria inside the cells. Who this helps: This helps cancer patients undergoing photodynamic therapy.

Plain English
This study looked at new types of water-soluble compounds called porphyrins to see if they could be better at treating cancer using a method called photodynamic therapy (PDT). The researchers found that some of these new compounds killed 50% of cancer cells at lower doses than a common treatment called Photofrin, using much less of the sensitizer (as little as 5.7 mg per kg) and specific light settings. This is important because it could lead to more effective and safer cancer treatments with fewer side effects. Who this helps: This helps cancer patients and doctors looking for better treatment options.

Plain English
The study looked at new types of dyes called chalcogenopyrylium dyes, which are related to a known cancer treatment dye called AA1. Researchers tested these dyes for their ability to harm cancer cells both in the dark and when exposed to light. They found that certain dyes, like 1-S and 3-Se, were particularly effective when light was shone on them, showing that they could target cancer cells more precisely, with some having a “therapeutic ratio” indicating better performance at high light exposure without harming normal cells. Who this helps: This research benefits cancer patients by potentially leading to more effective treatments.

Plain English
This study looked at how a specific enzyme, delta-aminolevulinic acid dehydratase (ALA-D), affects the production of a compound called protoporphyrin IX (PPIX) in breast and other cancer cell lines after exposure to delta-aminolevulinic acid (ALA). Researchers found that when these cells were treated with ALA, PPIX levels increased significantly, but ALA-D activity didn't change, suggesting ALA-D is an important early step in making the PPIX which is used in certain cancer treatments. The findings highlight that correctly managing this enzyme may improve the effectiveness of cancer therapies that depend on PPIX. Who this helps: Patients undergoing photodynamic therapy for cancer.

Plain English
This study investigated a new type of compound that can be used in photodynamic therapy (PDT), which treats cancer by using light and a special drug to kill cancer cells. The researchers found that one of the compounds, referred to as "1," was effective at low doses, killing 50% of cancer cells at concentrations of less than 25 micrograms per milliliter, while another common compound required more than 100 micrograms per milliliter to achieve the same result. Importantly, this new compound did not cause toxicity in mice after being injected, and it also accumulated in cancer tumors when tested in live mice. Who this helps: This helps cancer patients needing effective treatments with fewer side effects.

Plain English
This study focused on a new substance called selenopyrylium dye, which has potential for treating cancer using light (a method known as photodynamic therapy). Researchers found that this dye was effective in slowing the growth of tumors in rats, with treated tumors taking about 9 days to double in size compared to just 3 days for untreated tumors, indicating a significant delay in cancer progression. Importantly, this substance did not cause long-lasting skin damage in animals, which is a common problem with other similar treatments. Who this helps: This benefits cancer patients by providing a potentially safer and more effective treatment option.

Plain English
This study looked at new dyes that might help treat cancer using light therapy. Researchers found that three different dyes were effective at killing cancer cells by generating a type of reactive oxygen when exposed to light, with one dye showing the highest effectiveness. Importantly, these dyes did not show toxicity at a safe dose, which means they could be promising tools for cancer treatments. Who this helps: Patients undergoing photodynamic therapy for cancer.

Plain English
This study focused on creating and testing new dyes that could help treat cancer using a method called photodynamic therapy (PDT). Researchers found that two specific dyes, selenopyrylium dyes 3a and 3d, were effective in killing cancer cells in lab tests, with rates of toxicity observed at 0.040 and 0.045 for generating a type of reactive oxygen that damages cells. The study is important because it shows promise for these dyes to aid in cancer treatment without the expected toxicity in animal tests, indicating a potential path forward in developing new cancer therapies. Who this helps: Patients undergoing cancer treatment may benefit from these new dye-based therapies.

Plain English
This study looked at how levels of a compound called protoporphyrin IX, which can be produced by certain tumor cells when a substance called delta-aminolevulinic acid is added, relate to the amount of mitochondria in those cells. The researchers found that different cancer cell types produced different amounts of protoporphyrin IX, and this production was linked to how many mitochondria the cells had. This is important because the findings could help doctors predict which tumors are more likely to respond to a type of cancer treatment called photodynamic therapy, which uses light to activate the photosensitizing compound. Who this helps: This helps patients with cancer by identifying which tumors may be more effectively treated with light therapy.

Plain English
This study looked at how hormones, particularly estrogen, affect the response of certain cancer cells and related glands in rats when treated with a specific compound (delta-aminolevulinic acid). The researchers found that removing the ovaries from female rats reduced protoporphyrin IX levels and enzyme activity in tumors, which was significant (4.9 days to double tumor volume in ovariectomized rats compared to 10.6 days in intact rats). This matters because it shows that a patient's hormonal status can influence the effectiveness of cancer treatments that use light-based therapies. Who this helps: This helps cancer patients, particularly those with hormonally sensitive tumors.

Plain English
This study looked at a treatment called neural therapy, which is similar to acupuncture, for patients with multiple sclerosis. Researchers found that 65% of patients in an initial pilot study and 76% in a more rigorous double-blind study showed improvements in their condition after treatment, with benefits lasting for years. This matters because it provides a new, safe, and affordable option for managing multiple sclerosis symptoms. Who this helps: Patients with multiple sclerosis.